SCHEMBL2300206

SCHEMBL2300206

CNC(=O)C=C(c1ccccc1)c1ccc2cc[nH]c2c1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ CYP1A1 P04798 3/20 0.33
▸ CYP1B1 Q16678 3/20 0.33
▸ BCHE P06276 3/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TUBB4A P04350 2/20 0.32
▸ TUBB P07437 2/20 0.32
▸ TUBA3C P0DPH7 2/20 0.32
▸ TUBA1B P68363 2/20 0.32
▸ TUBA4A P68366 2/20 0.32
▸ TUBB4B P68371 2/20 0.32
▸ TUBB3 Q13509 2/20 0.32
▸ TUBB2A Q13885 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300204 1.00 KEAP1 (0.35) KEAP1BTKTSHRCYP1A1CYP1B1
SCHEMBL2301218 0.82 MAPT (0.36) KEAP1CYP1A1CYP1B1BCHEABCB1
SCHEMBL2302396 0.82 MAPT (0.36) KEAP1CYP1A1CYP1B1BCHEABCB1
SCHEMBL14014132 0.82 MAPT (0.36) KEAP1CYP1A1CYP1B1BCHEABCB1
SCHEMBL12427603 0.82 KEAP1 (0.52) KEAP1BCHEMAPK1KDM4EMAPT
SCHEMBL4751118 0.82 KEAP1 (0.52) KEAP1BCHEMAPK1KDM4EMAPT
SCHEMBL4751117 0.82 KEAP1 (0.52) KEAP1BCHEMAPK1KDM4EMAPT
SCHEMBL1162240 0.74 KDM4E (0.42) KEAP1BCHEKDM4ETUBB4ATUBB
SCHEMBL28878115 0.74 KEAP1 (0.53) KEAP1BCHEMAPK1KDM4EMAPT
SCHEMBL2300843 0.72 CYP2D6 (0.43) KEAP1MAPTCDK8CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351737-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles F. Hoffmann-La Roche AG (CH) 2011-08-03 — — EP disclosed
US-7803830-B2 3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2010-09-28 — — US disclosed
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2009-04-16 — — US disclosed
US-7446118-B2 3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC (US) 2008-11-04 — — US disclosed
EP-1960355-A1 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-27 — — EP disclosed
WO-2007062996-A1 3-AMINO-1-ARYLPROPYL INDOLES AND AZA-SUBSTITUTED INDOLES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 — — WO disclosed
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof ROCHE PALO ALTO LLC 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123527-A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof IDO1, RB1, AHR KEAP1 3292/4885BTK 1947/4885TSHR 271/4885
US-20090099236-A1 3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof IDO1, RB1, AHR KEAP1 3292/4885BTK 1947/4885TSHR 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback